In this webinar, the third in the “New Frontiers in Liquid Biopsy Research” series, Dr. Liya Xu of the University of Southern California Michelson Center for Convergent Biosciences discusses her team’s work using liquid biopsy technology for breast cancer research.
May 22, 2018
Sponsored by
Thermo Fisher Scientific
From Qualitative to Quantitative: Experiences with a cfDNA Assay in Metastatic Breast Cancer
Genome Webinar
Join or Log in for Access
This content is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.
Sponsored by
